1258728

Llorens Pharmaceuticals International Division, Inc. — FEI 3008468946

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 15, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Miami, FL (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
192021 CFR 211.166(a)(3)Valid stability test methods